Related Experiment Video
Updated: Mar 31, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Author's Reply to "Can artificial intelligence transform cardiomyopathy diagnosis and risk stratification in the
Salah H Alahwany1,2, Ahmed Ammar2,3
1Arrhythmogenic Cardiomyopathy Program, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.
No abstract available in PubMed .
More Related Videos
10:30Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management